Dipeptidyl Peptidase 4 (DPP4) Exacerbates Osteoarthritis Progression in an Enzyme‐Independent Manner
Advanced Science · 2025-02 · 12 (6)
DOI: 10.1002/advs.202410525 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 16.12.2024. Verfasst von Xinyu Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Orthopaedic Research Institute, West China Hospital, West China Medical School, Sichuan University, Chengdu, 61004…. Hauptthemen laut MEDLINE: Dipeptidyl Peptidase 4, Osteoarthritis, Chondrocytes. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, SiChuan Science and Technology Program, National Key Research and Developmental Plan.
Abstract (Originalsprache)
Chondrocyte senescence is a key driver of osteoarthritis (OA). Mitochondrial dysfunction and oxidative stress can induce chondrocyte senescence. However, the specific mechanisms by which senescence contributes to OA progression are not fully understood. Here, it is attested that Dipeptidyl peptidase 4 (DPP4) is significantly upregulated in osteoarthritic chondrocytes in both humans and mice. DPP4 promotes oxidative stress and cellular senescence in chondrocytes through excessive mitochondrial fission in an enzyme‐independent manner. Intra‐articular injection of adeno‐associated virus 2 to upregulate DPP4 in chondrocytes promotes post‐traumatic and aging‐induced OA in mice in an enzyme‐independent manner. Mechanistically, DPP4 competitively binds to Myosin heavy chain 9 (MYH9), interfering with its E3 ubiquitin ligase Carboxyl terminus of Hsc70‐interacting protein (CHIP), and thereby upregulates MYH9 expression. Finally, a small molecule, 4,5‐Dicaffeoylquinic acid is identified, which disrupts the interaction between DPP4 and MYH9, thereby ameliorating post‐traumatic and aging‐induced OA in mice caused by DPP4 upregulation. The study indicates that the non‐enzymatic activity of DPP4 is a promising target for OA treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Orthopaedic Research Institute, West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, China.
- Department of Immuno-Oncology, Beckman Research Institute at City of Hope, National Medical Center, Duarte, 91010, USA.
ORCID-Profile: Zeyu Huang
Förderung
- National Natural Science Foundation of China
- SiChuan Science and Technology Program
- National Key Research and Developmental Plan
Zitieren
APA
Li, X., Zhang, Z., Jiang, W., Ju, Y., Guo, W., & Huang, Z. (2025). Dipeptidyl Peptidase 4 (DPP4) Exacerbates Osteoarthritis Progression in an Enzyme‐Independent Manner. Advanced Science, 12(6). https://doi.org/10.1002/advs.202410525
Vancouver
Li X, Zhang Z, Jiang W, Ju Y, Guo W, Huang Z. Dipeptidyl Peptidase 4 (DPP4) Exacerbates Osteoarthritis Progression in an Enzyme‐Independent Manner. Advanced Science. 2025;12(6). doi:10.1002/advs.202410525
BibTeX
@article{Li2025,
author = {Li, Xinyu and Zhang, Zhao and Jiang, Wenyu and Ju, Yucan and Guo, Weihua and Huang, Zeyu},
title = {Dipeptidyl Peptidase 4 (DPP4) Exacerbates Osteoarthritis Progression in an Enzyme‐Independent Manner},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {6},
doi = {10.1002/advs.202410525}
}
EUVIMED